The planarian Dugesia japonica has a powerful regenerative capacity and can regenerate its whole body, including complete and functional restoration of its central nervous system (CNS) within one week. In our previous works, down-regulation of DjPLCβ led to defects in brain regeneration that resulted in incomplete brain development, suppression of DjGAD protein expression, and reduction of GABAergic neurons. U73122 is an aminosteroid inhibitor of phospholipase C (PLC), which plays an inhibitory role in many different types of cells, such as platelets, neutrophils, and neuroblastoma cells. m-3M3FBS is an activator that stimulates PLC activity. This study aimed to investigate whether PLCβ could be used as a drug target for GABAergic neuron regeneration. Herein, planarianns were treated with 0.2 μM U73122 or alternatively first treated with 0.2 μM U73122 and then with 1 μM m-3M3FBS for 1 h, and the expression pattern of DjGAD and DjPLCβ in the brain was analyzed by immunohistochemistry; level of DjGAD mRNA and DjPLCβ protein were analyzed by whole-mount in situ hybridization (WISH) and western blotting, respectively. The results showed that U73122 can strongly inhibit DjPLCβ and DjGAD protein expression and cause neuronal defects in planarian. m-3M3FBS rescued the expression of DjPLCβ and DjGAD proteins and mitigated the associated neuronal defects. These results suggest that U73122 and m-3M3FBS may regulate GABAergic neuron regeneration in planarian, and that PLCβ can be used as a novel drug target for GABAergic neuron regeneration following disease-induced neuron loss.